One in five
Americans have tried and/or are regularly using CBD
52%
of US consumers who have tried CBD used it as an alternative to traditional pain medications
60%
of CBD users say they are willing to pay more for a healthcare product containing CBD
Based on a 2019 Grail Insights’ survey of 1,069 US consumers
Got questions about consumers and CBD?
We’ve got a lot to share about consumer usage and attitudes, including both the US and UK. Want insights by age, gender, country? Tell us what you’re looking for.
Why should you care about CBD?
As legalization grows, patients are increasingly open to using it as an alternative to traditional pharmaceutical pain products. This is already causing market disruption. But we are also seeing opportunities for Pharma. Learn more about how and why patients are switching.
About Grail Insights Healthcare
Grail’s Healthcare team helps clients navigate the shifting healthcare landscape so they can make swift and sound business decisions. Leading pharmaceutical companies work with us to understand patient needs, spot opportunities, and be quick to market.
Clients choose Grail to:
- Find white space opportunities in fast-moving markets
- Advance pipeline products from Stage 1 through to product launch
- Identify emerging markets and get there first
- Optimize supply chains
- Prepare for changing regulatory requirements
- Provide agile, flexible support
Prefer to talk?
Book a meeting for a 1:1 on CBD and your business